Emcure Pharmaceuticals Ltd.
EMCURE
Rangering i aksjer
#4333
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Aksjekurs
$18.81
Markedsverdi
$3.57B
Endring (1 dag)
-3.13%
Endring (1 år)
18.91%
Land
IN
Handel Emcure Pharmaceuticals Ltd. (EMCURE)
Kategori
Healthcare
Aksjeprishistorikk for Emcure Pharmaceuticals Ltd. (EMCURE)
Høyeste sluttskurs: $20.40 den 2026-10-01
Laveste sluttskurs: $15.91 den 2024-07-01
Laveste sluttskurs: $15.91 den 2024-07-01
Aksjeprishistorikk for Emcure Pharmaceuticals Ltd. fra 2024 til 2026
Årlig aksjeprisytelse
| År | Ytelse |
|---|---|
| 2026 (TTM) | 16.96% |
| 2025 | -4.84% |
| 2024 | 0.00% |
Aksjepris for lignende selskaper eller konkurrenter
| Selskap | Aksjepris | Endring 1år% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
